Gain Therapeutics, Inc. (GANX) Earnings
|
Expand Research on GANX
| Next EPS Date | 11/18/26 | EPS Growth Rate | +13.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +4.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +7.0% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/26  |
Q326 | N/A | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.11 | -$0.14 | +$0.03 | N/A | N/A | N/A |  | | Details | |
| 5/11/26 |
Q126 | -$0.13 | -$0.14 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 3/26/26 |
Q425 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/25/26 |
Q425 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/23/26 |
Q425 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/19/26 |
Q425 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A |
